ENGLISH EDITION · UPDATED WEEKLY

InLight Bio

New biomedical science, read from the primary paper: organoids, disease models, AI drug design, immunology, antibodies, nucleic-acid medicines and precision oncology. Plus China biopharma deals and partnering events, each linked to its source.

36 science briefs13 deal briefs26 events listed

Latest science

All science →

Latest deals & data

All deals →

Novartis takes global rights to Abogen's in vivo mRNA T-cell engager ABO2203

$575M upfront; up to ~$7.8B total
Oct 2026Licensing

Simcere Zaiming licenses CD79a×CD19×CD3 trispecific SIM0660 to Roche

Up to $1.53B total
Sep 2026Licensing

Upcoming conferences

All events →

Working on a China asset, a NewCo or a landscape report? See Services →

One email a week, in English

New science briefs, China out-licensing and NewCo deals, each with a link to the original source. Free; unsubscribe any time.

Subscribe